Table 1 Basic cohort data including patients’ demographics, peri- and postoperative anaesthetic procedural data and medications (615 patients) T-test/chi-square evaluation of the main study populations (NMBA+/NMBA-)
From: Recovery and prediction of postoperative muscle power – is it still a problem?
Cohort data (n = 615) | NMBA+ (n = 347) | NMBA– (n = 268) | p-Value | |
|---|---|---|---|---|
Gender (M/F) | 278/337 | 185/162 | 93/175 | 0.001 |
Age | 53 ± 15 | 55 ± 14 | 50 ± 16 | 0.001 |
BMI | 27.5 ± 4.9 | 28 ± 5.0 | 26.4 ± 4.5 | 0.001 |
TIVA/Balanced Anaesthesia (n) | 378/237 | 74/273 | 105/163 | 0.001 |
Premedication (Clorazepat mg) | 27 ± 12 | 28 ± 11 | 26 ± 11 | 0.059 |
Fentanyl (mg) | 0.44 ± 0.3 | 0.49 ± 0.2 | 0.36 ± 0.2 | 0.001 |
BIS intraoperative | 39 ± 7 | 38 ± 6 | 39 ± 7 | 0.0141 |
BIS end | 42 ± 11 | 42 ± 10 | 43 ± 11 | 0.174 |
Metamizole (mg) | 1.7 ± 0.5 | 1.7 ± 0.5 | 1.6 ± 0.4 | 0.068 |
Piritramide (mg) | 7.8 ± 4.5 | 7.9 ± 4.0 | 7.6 ± 5.0 | 0.480 |
Anaesthesia time (min) | 130 ± 51 | 139 ± 43 | 117 ± 45 | 0.001 |
Fast Track score > 10 PACU (min) | 25 ± 21 | 28 ± 23 | 22 ± 16 | 0.001 |
SpO2.pre-OP (%) | 97.2 ± 1.5 | 97.0 ± 1.5 | 97.4 ± 1.4 | 0.002 |